Zynerba Pharmaceuticals (ZYNE) News Today

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)

Notice: This company has been marked as potentially delisted and may not be actively trading.

Stock Analysis

Source

Source	Headline
	Harmony Biosciences Reports Strong Third Quarter 2023 Financial Results finance.yahoo.com - October 31 at 7:57 AM
	Why Shares of Harmony Bioscience Are Falling on Friday fool.com - October 13 at 12:59 PM
	New Possibilities For Cannabinoid Treatments: Acquisition To Transform Neuropsychiatric Disorder Therapies markets.businessinsider.com - October 11 at 9:47 AM
	HARMONY BIOSCIENCES COMPLETES ACQUISITION OF ZYNERBA PHARMACEUTICALS AND EXPANDS PIPELINE finance.yahoo.com - October 11 at 9:47 AM
	marketbeat.com - October 11 at 6:05 AM
	Important Information for Zynerba Pharmaceuticals Stockholders to Tender Shares for the Harmony Transaction: Process and Instructions finance.yahoo.com - October 4 at 7:33 PM
	20 Countries With Highest Rate of Epilepsy finance.yahoo.com - September 29 at 6:24 PM
	Zynerba Pharmaceuticals Stockholders Reminded to Tender Shares Before 5:00 PM New York City Time, on Tuesday October 10, 2023 finance.yahoo.com - September 29 at 1:23 PM
	Harmony Biosciences extends deadline for Zynerba shareholders on up to $200M deal bizjournals.com - September 27 at 2:42 PM
	marketbeat.com - September 27 at 6:06 AM
	Insider Sell: President Terri Sebree Sells 12,401 Shares of Zynerba Pharmaceuticals Inc finance.yahoo.com - September 14 at 11:23 PM
	Zynerba Pharmaceuticals Presents Positive Data from Phase 2 INSPIRE Trial in 22q11.2 Deletion Syndrome at The Society for the Study of Behavioural Phenotypes (SSBP) 25th International Research Symposium finance.yahoo.com - September 14 at 6:23 PM
	HC Wainwright & Co. Downgrades Zynerba Pharmaceuticals (ZYNE) msn.com - August 16 at 4:20 AM
	Is Zynerba Pharmaceuticals (NASDAQ:ZYNE) In A Good Position To Deliver On Growth Plans? finance.yahoo.com - August 15 at 6:19 PM
	Zynerba Pharmaceuticals Shares Soar on Harmony Biosciences Deal >ZYNE marketwatch.com - August 14 at 9:48 PM
	Crude Oil Down 1%; Zynerba Pharmaceuticals Shares Spike Higher markets.businessinsider.com - August 14 at 4:48 PM
	ZYNE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Zynerba Pharmaceuticals, Inc. Is Fair to Shareholders technews.tmcnet.com - August 14 at 8:57 AM
	HARMONY BIOSCIENCES TO ACQUIRE ZYNERBA PHARMACEUTICALS, INC. finance.yahoo.com - August 14 at 8:57 AM
	marketbeat.com - August 14 at 7:28 AM
	Zynerba Pharmaceuticals Announces New Date for Reconvened Annual Meeting finance.yahoo.com - July 25 at 8:42 PM
	Zynerba (ZYNE) Upgraded to Buy: What Does It Mean for the Stock? finance.yahoo.com - June 29 at 3:11 PM
	Zynerba Pharmaceuticals Announces Further Adjournment of Annual Meeting finance.yahoo.com - June 28 at 6:08 PM
	Zynerba Pharmaceuticals to Present at the H.C. Wainwright 4th Annual Neuropsychiatry Virtual Conference finance.yahoo.com - June 20 at 7:48 AM
	Zynerba Pharmaceuticals Announces Partial Adjournment of Annual Meeting finance.yahoo.com - June 13 at 6:31 PM
	Main Line CBD drug developer plans reverse stock split to boost share price bizjournals.com - May 17 at 4:40 PM
	Zynerba Pharmaceuticals, Inc.: Zynerba Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Highlights finanznachrichten.de - May 15 at 10:42 AM
	Zynerba Pharma (ZYNE) Earnings Dates & Reports investing.com - May 15 at 10:42 AM
	Zynerba Pharmaceuticals R&D Expenses For Q1 Reach $7.1M, Here Are The Details msn.com - May 15 at 10:42 AM
	Zynerba Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Highlights finance.yahoo.com - May 15 at 10:42 AM
	Zynerba Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Highlights finance.yahoo.com - May 15 at 10:42 AM
	Fibromyalgia Treatment Drug Market Overview and Scope By 2030 marketwatch.com - April 18 at 11:10 PM
	Zynerba Pharmaceuticals Presents Data on Zygel(TM) at the 55th Gatlinburg Conference marketwatch.com - April 14 at 12:45 AM
	Zynerba Pharmaceuticals Presents Data on Zygel™ at the 55th Gatlinburg Conference finance.yahoo.com - April 12 at 9:57 AM
	Zynerba Pharmaceuticals Announces Poster Presentations at the 55th Gatlinburg Conference finance.yahoo.com - April 5 at 7:39 AM
	Zynerba Pharmaceuticals, Inc.: Zynerba Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights finanznachrichten.de - March 28 at 1:26 PM
	Zynerba Pharmaceuticals R&D Expenses For FY22 Reach $21.1M, What About Net Loss? benzinga.com - March 28 at 1:26 PM
	Zynerba Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights finance.yahoo.com - March 28 at 8:25 AM
	Zynerba Pharmaceuticals, Inc.: Zynerba Pharmaceuticals Confirms Not Holding Cash Deposits or Securities at Silicon Valley Bank finanznachrichten.de - March 14 at 4:14 AM
	Zynerba Pharmaceuticals Confirms Not Holding Cash Deposits or Securities at Silicon Valley Bank finance.yahoo.com - March 13 at 6:11 PM
	Analysts Conflicted on These Healthcare Names: BioMarin Pharmaceutical (BMRN) and Armata Pharmaceuticals (ARMP) markets.businessinsider.com - March 7 at 7:14 AM
	Zynerba Pharmaceuticals to Present at the Oppenheimer 33rd Annual Healthcare Conference finance.yahoo.com - March 7 at 7:14 AM
	Zynerba Pharmaceuticals to Present at the Cowen 43rd Annual Health Care Conference finance.yahoo.com - March 1 at 8:39 AM
	Fibromyalgia Treatment Drug Market Outlook 2023 and Forecast to 2028 with Top Countries Data marketwatch.com - February 21 at 9:36 AM
	2023, Pain Management Drugs Market to Experience a Significant Increase in Revenues by 2027 marketwatch.com - February 13 at 9:12 AM
	Fibromyalgia Treatment Drug Market 2023 : Profiling Key Players, Value Estimation and Analysis by Recent Trends to 2028 marketwatch.com - January 27 at 1:04 PM
	What's The Role Of The Endocannabinoid System In Fragile X Syndrome? How Can Cannabidiol Treatment Help? New Paper msn.com - January 12 at 1:23 AM
	Zynerba Pharmaceuticals Announces Publication in the Journal of Neurodevelopmental Disorders Describing the Role of the Endocannabinoid System and Cannabidiol Therapy in Fragile X Syndrome finance.yahoo.com - January 11 at 10:01 AM
	Zynerba Pharmaceuticals forbes.com - January 10 at 1:29 PM
	Zynerba Pharmaceuticals revises timeline for release of topline results from Phase 3 RECONNECT trial of Zygel in Fragile X syndrome proactiveinvestors.com - December 21 at 9:07 AM
	Zynerba Pharmaceuticals delays data on genetic disorder drug study finance.yahoo.com - December 21 at 9:07 AM

Get Zynerba Pharmaceuticals News Delivered to You Automatically

Secret Bull Market Starts in This Unusual Sector (Ad)

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

Click for my No. 1 investment, all free of charge, click here.

ZYNE Media Mentions By Week

ZYNE Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ZYNE
News Sentiment
▼
0.00

0.51
▲
Average
Medical
News Sentiment

ZYNE News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ZYNE Articles
This Week
▼
0

1
▲
ZYNE Articles
Average Week

Get Zynerba Pharmaceuticals News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:ZYNE) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Zynerba Pharmaceuticals (ZYNE) News Today

ZYNE Media Mentions By Week

ZYNE Media Sentiment

ZYNE News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info